Physician profile
Sarah E Harrison
NPI 1073822110
$1,728.21
in general payments reported to CMS, 2019-2025
24 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $173 · 2022: $193 · 2023: $517 · 2024: $425 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,262 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,262.34 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $436.26 | 2023-2024 | Veozah |
| Shield Therapeutics INC | $253.99 | 2023-2024 | Accrufer |
| Biogen, INC. | $219.05 | 2024-2025 | Zurzuvae |
| Organon LLC | $93.28 | 2022-2025 | Nexplanon |
| Tersera Therapeutics LLC | $67.84 | 2024 | |
| Optumhealth Care Solutions, LLC | $67.41 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Evofem Biosciences, INC. | $64.85 | 2021-2022 | |
| Abbvie INC. | $60.98 | 2021 | |
| Stryker Corporation | $56.80 | 2025 | Clottriever Bold Catheter |
| Mayne Pharma Commercial LLC | $56.17 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.39 | 2021-2022 | |
| Hologic Sales and Service, LLC | $38.28 | 2021-2023 | Aptima |
| Exeltis, USA INC. | $36.58 | 2021-2024 | Slynd |
| Agile Therapeutics, INC. | $31.22 | 2021-2022 | |
| Dexcom, INC. | $26.04 | 2025 | Dexcom G6 Transmitter |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $23.25 | 2022 | |
| Emd Serono, INC. | $21.72 | 2022 | |
| Conmed Corporation | $20.99 | 2025 | Airseal |
| Solventum Corporation | $19.51 | 2025 | Prevena |
| Scynexis, INC. | $19.29 | 2022 | |
| Pfizer INC. | $17.85 | 2023 | |
| Daiichi Sankyo INC. | $17.34 | 2021 | |
| Coopersurgical, INC. | $16.65 | 2022 | |
| Therapeuticsmd, INC. | $16.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.